The US Office of the Comptroller of the Currency (OCC) granted final approval to Ripple National Trust Bank to manage the reserves backing the RLUSD stablecoin, which has a market cap of $2.5 billion. This trust bank can hold and manage reserves but cannot take deposits or issue loans, meaning no FDIC insurance applies to RLUSD holders. Despite this US approval, RLUSD is not authorized as an e-money token in the EU under MiCA regulation, limiting its availability on European exchanges, with only one exchange offering a euro trading pair that sees no actual trading. European investors must buy RLUSD via other stablecoins, which has tax implications. The Ripple trust bank mainly targets US institutional clients, and the approval does not directly impact XRP token price or European retail investors.
Ripple National Trust Bank's RLUSD stablecoin has a market cap of $2.5 billion, providing context for readers following this story. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Oct 27, 2026 17:02 WIB: out of 50 major cryptocurrencies, 16 rose and 33 fell today. Notable movers include SXP (Solar) down 46.27% at Rp37 with a typical hold time of 94 days, BAL (Balancer) up 11.14% at Rp16,297 with a typical hold time of 85 days, and EOS (EOS.IO) up 8.13% at Rp12,649 with a typical hold time of 87 days.
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
Nautilus Biotechnology announced its Q3 2026 financial results, reporting $0.2 million in revenue mainly from grants and early access services, and a net loss of $15.6 million. The company highlighted progress in its proteome analysis platform, inclu...
Eviden, part of Atos Group, has introduced ASTRA-LAS, a tactical decision-support solution designed to aid naval officers in complex maritime environments. The system uses operational data and AI to enhance situational awareness, reduce cognitive loa...
